Related Experiment Video
Updated: May 18, 2026
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Stabilin-1 expression in tumor associated macrophages
Clément David1, J Philip Nance, Jacqueline Hubbard
1School of Medicine, Division of Biomedical Sciences, University of California, Riverside, CA 92521, USA.
Brain Research
|September 11, 2012
Summary
Researchers explored how immune cells impact glioblastoma multiforme, a deadly brain tumor. They found that stabilin-1 expressing macrophages, crucial for immune response, transiently appear and then disappear as the tumor progresses.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Glioblastoma multiforme is an aggressive brain tumor with poor prognosis despite current treatments.
- The tumor microenvironment often shows increased levels of secreted protein acidic and rich in cysteine (SPARC), influencing tumor progression.
- The immune system presents a promising avenue for novel glioblastoma therapies.
Purpose of the Study:
- To investigate the role of stabilin-1 expressing immune cells in the glioblastoma tumor environment.
- To understand the dynamic changes of these immune cells during tumor progression.
- To explore the potential of targeting stabilin-1 and SPARC interactions for glioblastoma treatment.
Main Methods:
- Phenotypic analysis of immune cells within the glioblastoma tumor microenvironment.
- Characterization of stabilin-1 expression on macrophages.
- Assessment of SPARC expression and its correlation with immune cell populations.
Main Results:
- A transient population of alternatively activated macrophages expressing stabilin-1 was identified in the tumor environment.
- The presence of these stabilin-1 expressing macrophages diminished as the glioblastoma tumor progressed.
- Stabilin-1's interaction with SPARC suggests a potential mechanism for tumor growth inhibition.
Conclusions:
- Alternatively activated macrophages expressing stabilin-1 play a transient role in the glioblastoma tumor microenvironment.
- The disappearance of these cells correlates with tumor progression, highlighting a potential therapeutic window.
- Targeting the stabilin-1/SPARC axis may offer a novel strategy for glioblastoma treatment.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17Microtubule Instability
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...